RTX Corporation (NYSE:RTX) shares are trading higher premarket on Monday after the company won an additional multi-million-dollar contract from the Danish Defence Armed Forces for ELCAN Specter DR dual-role sights.

The NATO Support Procurement Agency (NSPA) is overseeing the contract.

The ELCAN Specter DR sight is a versatile optic that enables both close-quarters and precision targeting in one device.

It seamlessly switches between magnifications, allowing users to maintain “both eyes open” target acquisition, while ensuring consistent boresight, eye relief, and sight picture.

Read: US, Russian Officials Begin Ukraine Peace Talks: Defense Sector Stocks Rise

Mike Lewis, director and general manager at Raytheon ELCAN said, “The Specter DR dual role sight is battle-proven, enabling soldiers to be more effective on the battlefield,”

“Raytheon ELCAN continues to work with our customers across NATO to deliver rugged, reliable optics that give our allies a competitive advantage when it matters most.”

Last week, Pratt & Whitney, a division of RTX , won a three-year contract worth up to $1.5 billion to support the U.S. Air Force's F119 engines, which power the F-22 fighter jets.

Last month, the company reported fourth-quarter results. Net sales increased 9% year-over-year to $21.623 billion, beating the consensus of $20.535 billion. Adjusted EPS grew 19% Y/Y to $1.54, above the consensus of $1.38.

Investors can gain exposure to the stock via iShares U.S. Aerospace & Defense ETF (BATS:ITA) and First Trust Exchange-Traded Fund First Trust Indxx Aerospace & Defense ETF (NYSE:MISL).

Price Action: RTX shares are up 1.30% at $124.89 premarket at the last check Monday.

Read Next:

• Trump Administration Orders Sweeping Pentagon Cuts: Palantir, Lockheed Martin, General Dynamics Among Stocks On Watch

Photo: Shutterstock